Next Article in Journal
Newborn Screening for Congenital Hypothyroidism in Japan
Next Article in Special Issue
Novel Modification of a Confirmatory SMA Sequencing Assay that Can Be Used to Determine SMN2 Copy Number
Previous Article in Journal
Glutaric Aciduria Type I Missed by Newborn Screening: Report of Four Cases from Three Families
Previous Article in Special Issue
Massachusetts’ Findings from Statewide Newborn Screening for Spinal Muscular Atrophy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJNS
Volume 7
Issue 3
10.3390/ijns7030033
IJNS-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021

by
Kshea Hale
*,
Jelili Ojodu
and
Sikha Singh
Association of Public Health Laboratories, Silver Spring, MD 20910, USA
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2021, 7(3), 33; https://doi.org/10.3390/ijns7030033
Submission received: 21 May 2021 / Revised: 11 June 2021 / Accepted: 16 June 2021 / Published: 24 June 2021
(This article belongs to the Special Issue Newborn Screening for Spinal Muscular Atrophy)
Browse Figures
Versions Notes

Abstract

Newborn screening (NBS) programs identify newborns at increased risk for genetic disorders, linking these newborns to timely intervention and potentially life-saving treatment. In the United States, the Health and Human Services (HHS) Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) recommends the disorders for state NBS programs to screen. ACHDNC updated the Recommended Uniform Screening Panel to include Spinal Muscular Atrophy (SMA) in July 2018. As of June 2021, 34 state NBS programs had fully implemented SMA newborn screening, and at least 8 programs were pursuing implementation. This article will review current SMA screening processes, considerations, challenges, and status.
Keywords: newborn screening; spinal muscular atrophy; new disorders implementation newborn screening; spinal muscular atrophy; new disorders implementation

Share and Cite

MDPI and ACS Style

Hale, K.; Ojodu, J.; Singh, S. Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021. Int. J. Neonatal Screen. 2021, 7, 33. https://doi.org/10.3390/ijns7030033

AMA Style

Hale K, Ojodu J, Singh S. Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021. International Journal of Neonatal Screening. 2021; 7(3):33. https://doi.org/10.3390/ijns7030033

Chicago/Turabian Style

Hale, Kshea, Jelili Ojodu, and Sikha Singh. 2021. "Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021" International Journal of Neonatal Screening 7, no. 3: 33. https://doi.org/10.3390/ijns7030033

APA Style

Hale, K., Ojodu, J., & Singh, S. (2021). Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021. International Journal of Neonatal Screening, 7(3), 33. https://doi.org/10.3390/ijns7030033

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop